CLINICAL_TRIALS
trial_result
· 2017-06-20
Clinical Trial Update: To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis [Phase 3]
Summary
Phase 3 trial evaluating the auto-injector device for sarilumab in rheumatoid arthritis has completed, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: RA | Phase 3 | Status: COMPLETED | Results posted: 2017-06-20